Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lenihan

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Cardio-Oncology (London, England)|January 5, 2023
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survivalChristine Auberle, Daniel Lenihan, Feng Gao, et al.
Journal of Oncology|September 9, 2015
Cancer and Cardiovascular Disease: The Complex LabyrinthSusan Dent, Peter Liu, Christine Brezden-Masley, et al.
The Oncologist|February 9, 2010
Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?Christos Vaklavas, Daniel Lenihan, Razelle Kurzrock, et al.
The American Journal of the Medical Sciences|May 31, 2016
Getting the SCOOP-Survey of Cardiovascular Outcomes From Oncology Patients During SurvivorshipNirmanmoh Bhatia, Daniel Lenihan, Douglas B Sawyer, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2017
Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United StatesAnna D Coutinho, Dinara Makenbaeva, Eileen Farrelly, et al.
Seminars in Oncology|December 1, 2019
Cardio-oncological management of patientsDaniela M Cardinale, Ana Barac, Adam Torbicki, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 29, 2021
Myocardial uptake of <sup>68</sup>Ga-DOTATATE: correlation with cardiac disease and risk factorsMalak Itani, Adeel Haq, Manik Amin, et al.
CA: a Cancer Journal for Clinicians|February 27, 2016
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and managementGiuseppe Curigliano, Daniela Cardinale, Susan Dent, et al.
Journal of Cardiac Failure|August 2, 2008
Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failureAnecita Fadol, Tito Mendoza, Ibrahima Gning, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ-IC-OS survey-based studyHasan Ali Farhan, Israa Fadhil Yaseen, Mohammed Alomar, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Cardio-Oncology (London, England)|January 5, 2023
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survivalChristine Auberle, Daniel Lenihan, Feng Gao, et al.
Journal of Oncology|September 9, 2015
Cancer and Cardiovascular Disease: The Complex LabyrinthSusan Dent, Peter Liu, Christine Brezden-Masley, et al.
The Oncologist|February 9, 2010
Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?Christos Vaklavas, Daniel Lenihan, Razelle Kurzrock, et al.
The American Journal of the Medical Sciences|May 31, 2016
Getting the SCOOP-Survey of Cardiovascular Outcomes From Oncology Patients During SurvivorshipNirmanmoh Bhatia, Daniel Lenihan, Douglas B Sawyer, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2017
Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous Leukemia Seen in Community-based Oncology Practices in the United StatesAnna D Coutinho, Dinara Makenbaeva, Eileen Farrelly, et al.
Seminars in Oncology|December 1, 2019
Cardio-oncological management of patientsDaniela M Cardinale, Ana Barac, Adam Torbicki, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 29, 2021
Myocardial uptake of <sup>68</sup>Ga-DOTATATE: correlation with cardiac disease and risk factorsMalak Itani, Adeel Haq, Manik Amin, et al.
CA: a Cancer Journal for Clinicians|February 27, 2016
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and managementGiuseppe Curigliano, Daniela Cardinale, Susan Dent, et al.
Journal of Cardiac Failure|August 2, 2008
Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failureAnecita Fadol, Tito Mendoza, Ibrahima Gning, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ-IC-OS survey-based studyHasan Ali Farhan, Israa Fadhil Yaseen, Mohammed Alomar, et al.
Pageof 8